Dr. Radin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
144 Morgan St
Suite
Stamford, CT 06905Phone+1 203-359-4888Fax+1 203-359-6983
Summary
- Dr. David Radin is an internist in Stamford, CT and is affiliated with Stamford Hospital. He received his medical degree from New York Medical College and has been in practice 230 years. He is experienced in preventive medicine, clinical research, and diagnostics.
Education & Training
- New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Internal Medicine, 1990 - 1993
- New York Medical CollegeClass of 1990
- Massachusetts Institute of TechnologyBS, Chemistry, 1979 - 1983
Certifications & Licensure
- CT State Medical License 1993 - 2024
- NY State Medical License 1992 - 1999
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top Doctors New York Metro Area Castle Connolly, 2020-2022
- Top Doctors New York Magazine, 2021
- Diabetes Recognition Program NCQA
- Join now to see all
Clinical Trials
- Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine. Start of enrollment: 2001 Sep 01
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain Start of enrollment: 2004 Feb 01
- Study of Milnacipran for the Treatment of Fibromyalgia Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 163 citationsTanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.Mark T. Brown, Frederick T. Murphy, David M. Radin, Isabelle Davignon, Michael D. Smith
The Journal of Pain. 2012-08-01 - 40 citationsPooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hipLeslie Tive, Alfonso E. Bello, David M. Radin, Thomas J. Schnitzer, Ha Nguyen
Journal of Pain Research. 2019-03-19 - 100 citationsTanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.Mark T. Brown, Frederick T. Murphy, David M. Radin, Isabelle Davignon, Michael D. Smith
Arthritis and Rheumatism. 2013-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: